Glaxo/Pfizer HIV Drug Collaboration
There’s an interesting story in the WSJ about a merger between the HIV-drug businesses at Glaxo and Pfizer. Some details from the story… Read the . . .
Glaxo/Pfizer HIV Drug Collaboration
Crane on Carrier’s Innovation in the 21st Century
Congratulations to Mike on a very fine book, which I must admit I am still in the process of digesting. I will confine my initial . . .
Weiser on Carrier’s Innovation in the 21st Century
It is trite to say that “we are all Schumpeterians now.” When it comes to appreciating the importance of innovation and entrepreneurship, however, we are. . . .
TOTM/ Patently-O Blog Symposium: Michael Carrier’s Innovation for the 21st Century
On March 30th and 31st, TOTM will hold its first blog symposium. The topic will be Michael Carrier’s (Rutgers) forthcoming book: Innovation for the 21st . . .
Odd FTC Consent in Vertical Licensing Case
The FTC announced a complaint today challenging Fresenius Medical Care AG & Co.’s proposed acquisition of an exclusive sublicense from Luitpold Pharmaceuticals, who is in . . .
Our “Protective” FDA
The FDA, it seems, is rejecting more new drugs. The agency approved only 61 percent of 2007 drug applications through mid-August, down from 73 percent . . .
Isn’t Competition Grand?: Wal-Mart, Drugs, and Antitrust
Fred Tung highlights Wal-Mart’s new strategy of selling a month’s supply of 300 different generics for $4, noting that Target will match Wal-Mart’s prices but . . .
J&J’s Bundled Discounts Victory
As reported here, Johnson & Johnson scored a major victory last week in a case challenging some of its discounting practices. The jury concluded that . . .
Organ Markets, Social Justice, and the Poor: A Reply to Professor Pasquale
Frank Pasquale at Madisonian is concerned that organ markets do not show enough concern for the poor. He writes… Read the full piece here.